Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1985 Jul;49(1):116-21.
doi: 10.1128/iai.49.1.116-121.1985.

Susceptibility of Propionibacterium acnes to killing and degradation by human neutrophils and monocytes in vitro

Susceptibility of Propionibacterium acnes to killing and degradation by human neutrophils and monocytes in vitro

G F Webster et al. Infect Immun. 1985 Jul.

Abstract

Propionibacterium acnes, the target of inflammation in acne, was tested for its sensitivity to the bactericidal and degradative functions of human polymorphonuclear leukocytes (PMN), monocytes, and their fractions. P. acnes strains were not killed by PMN under any conditions and were variably killed by monocytes in the presence of serum from acne patients. Control strains of Staphylococcus aureus and Micrococcus lysodeicticus were susceptible to both PMN and monocyte killing. P. acnes strains were also not killed by lysozyme, chymotrypsin, H2O2, human serum, PMN granule lysate, and PMN and monocyte cell lysates. The organism was sensitive to the bactericidal activity of myeloperoxidase in acid pH. In addition, P. acnes was shown to be relatively resistant to the degradative action of PMN and monocyte lysates, whereas M. lysodeicticus, S. aureus, and Staphylococcus epidermidis were all degraded to various degrees. The moieties that were liberated from P. acnes by PMN enzymes were predominantly low in molecular weight (1,000 to 25,000) and were consistent with cell wall fragments.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Exp Med. 1966 Nov 1;124(5):921-52 - PubMed
    1. J Exp Med. 1963 Jan 1;117:27-42 - PubMed
    1. J Pathol. 1970 Aug;101(4):339-54 - PubMed
    1. J Invest Dermatol. 1974 Mar;62(3):268-87 - PubMed
    1. J Infect Dis. 1974 May;129(5):528-37 - PubMed

Publication types